NCT06424080

Brief Summary

partial nephrectomy offers lower renal function impairment and equivalent oncological survival outcomes compared with radical nephrectomy in those with T1 tumors. As urology has embraced the gradual shift from open to minimally invasive surgery (MIS), PN is being completed more often by laparoscopic and robotic methods . The first laparoscopic transperitoneal partial nephrectomy was reported in 1993 by Winfield, with the retroperitoneal approach introduced 1 year later With advancing robotic technology and the development of the DaVinci system, urologists began to explore the realm of robotic-assisted urologic surgery. In 2004, Gettman et al. published a paper describing their experience with robotic-assisted laparoscopic partial nephrectomy. Moreover, robotic assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) seems to be significantly better than OPN in terms of perioperative complications, estimated blood loss and hospital stay. Conversely, transfusion rate, ischemia time, change in estimated glomerular filtration rate and early cancer outcomes are similar between the two approaches. International guidelines recommend the use of both approaches according to the surgeon and patient preferences. so, we are plaining to do the study comparing between RAPN and LPN regarding feasibility and ability of both techniques.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

June 4, 2024

Status Verified

June 1, 2024

Enrollment Period

1.5 years

First QC Date

May 13, 2024

Last Update Submit

June 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • to compare between laparoscopic and robotic partial nephrectomy regards ischemia time

    to compare between laparoscopic and robotic partial nephrectomy regards ischemia time

    1 year

Secondary Outcomes (1)

  • compare between laparoscopic and robotic partial nephrectomy pathological safty margin

    1 year

Study Arms (2)

laparoscopic partial nephrectomy

OTHER

cases of renal cell carcinoma , localized tumors , candidate for laparoscopic partial nephrectomy

Procedure: laparoscopic partial nephrectomy

robotic partial nephrectomy

OTHER

cases of renal cell carcinoma , localized tumors , candidate for robotic partial nephrectomy

Procedure: robotic partial nephrectomy

Interventions

cases amenable for partial nephrectomy

laparoscopic partial nephrectomy

cases amenable for partial nephrectomy

robotic partial nephrectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • renal mass T1 according to TNM amenable for partial nephrectomy.

You may not qualify if:

  • any unfit pt for partial nephrectomy
  • more than 7cm tumor
  • mass not amenable for partial nephrectomy
  • metastatic tumor or locally advanced

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hossam Kandeel

Shibīn al Kawm, Menoufia -, 12345, Egypt

RECRUITING

MeSH Terms

Conditions

Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsKidney NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Officials

  • hossam elsayed kandeel, MSC

    Director

    STUDY DIRECTOR

Central Study Contacts

hossam elsayed kandeel, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Yassin Abdelghaffar st-from Gamal Abdel Nasar st- faculty of medicine

Study Record Dates

First Submitted

May 13, 2024

First Posted

May 21, 2024

Study Start

May 1, 2024

Primary Completion

November 10, 2025

Study Completion

December 1, 2025

Last Updated

June 4, 2024

Record last verified: 2024-06

Locations